Federal contract award
75A50123C00036
ADVANCED DEVELOPMENT OF A NAAT MULTIPLEX RESPIRATORY PATHOGEN TEST FOR PROFESSIONAL POINT-OF- CARE (CLIA WAIVED) AND AT-HOME OTC USE WITH THE CUE HEALTH MONITORING SYSTEM (READER) AND CUE SAMPLE WAND
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | BARDA - ASPR / DAAPPO / BARDA DCMA |
| NAICS | 325413 — In-Vitro Diagnostic Substance Manufacturing |
| PSC | AN13 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | COST PLUS FIXED FEE |
| Obligations | $28.3M |
| Current contract value | $28.3M |
| Potential contract value / ceiling | $28.4M |
| Start date | Aug 2, 2023 |
| Current end date | Sep 30, 2026 |
| Potential end date | Sep 30, 2026 |
| Latest award activity | Jun 18, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 5 of 5 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Jun 18, 2026 | P00004 | $0 | ADVANCED DEVELOPMENT OF A NAAT MULTIPLEX RESPIRATORY PATHOGEN TEST FOR PROFESSIONAL POINT-OF- CARE (CLIA WAIVED) AND AT-HOME OTC USE WITH THE CUE HEALTH MONITORING SYSTEM (READER) AND CUE SAMPLE WAND |
| Mar 30, 2026 | P00003 | $0 | ADVANCED DEVELOPMENT OF A NAAT MULTIPLEX RESPIRATORY PATHOGEN TEST FOR PROFESSIONAL POINT-OF- CARE (CLIA WAIVED) AND AT-HOME OTC USE WITH THE CUE HEALTH MONITORING SYSTEM (READER) AND CUE SAMPLE WAND |
| Dec 17, 2025 | P00002 | $0 | ADVANCED DEVELOPMENT OF A NAAT MULTIPLEX RESPIRATORY PATHOGEN TEST FOR PROFESSIONAL POINT-OF- CARE (CLIA WAIVED) AND AT-HOME OTC USE WITH THE CUE HEALTH MONITORING SYSTEM (READER) AND CUE SAMPLE WAND |
| Nov 27, 2024 | P00001 | $0 | ADVANCED DEVELOPMENT OF A NAAT MULTIPLEX RESPIRATORY PATHOGEN TEST FOR PROFESSIONAL POINT-OF- CARE (CLIA WAIVED) AND AT-HOME OTC USE WITH THE CUE HEALTH MONITORING SYSTEM (READER) AND CUE SAMPLE WAND |
| Aug 2, 2023 | 0 | $28.3M | ADVANCED DEVELOPMENT OF A NAAT MULTIPLEX RESPIRATORY PATHOGEN TEST FOR PROFESSIONAL POINT-OF- CARE (CLIA WAIVED) AND AT-HOME OTC USE WITH THE CUE HEALTH MONITORING SYSTEM (READER) AND CUE SAMPLE WAND |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.